CorMedix (CRMD)
(Delayed Data from NSDQ)
$8.90 USD
+0.61 (7.36%)
Updated Oct 4, 2024 04:00 PM ET
After-Market: $8.90 0.00 (0.00%) 7:58 PM ET
2-Buy of 5 2
F Value F Growth B Momentum F VGM
Cash flow Statements
Fiscal Year End for CorMedix Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -46.34 | -29.70 | -28.21 | -22.03 | -16.43 |
Depreciation/Amortization & Depletion | 0.21 | 0.21 | 0.18 | 0.14 | 0.39 |
Net Change from Assets/Liabilities | 2.23 | 1.07 | 1.84 | -2.63 | -1.93 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 5.49 | 4.07 | 5.04 | 2.54 | 2.93 |
Net Cash From Operating Activities | -38.41 | -24.36 | -21.16 | -21.97 | -15.05 |
Property & Equipment | -0.33 | -0.22 | -1.43 | -0.11 | -0.04 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | -16.73 | -3.49 | -7.71 | 7.54 | -11.98 |
Other Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | -17.06 | -3.71 | -9.13 | 7.43 | -12.02 |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 56.12 | 17.77 | 41.76 | 40.10 | 24.03 |
Issuance (Repayment) of Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | -0.20 | 0.13 | 0.00 | 0.00 | 1.77 |
Net Cash from Financing Activities | 55.92 | 17.90 | 41.76 | 40.10 | 25.80 |
Effect of Exchange Rate Changes | 0.00 | -0.01 | -0.01 | 0.01 | 0.00 |
Net Change In Cash & Equivalents | 0.45 | -10.18 | 11.45 | 25.57 | -1.27 |
Cash at Beginning of Period | 43.37 | 53.55 | 42.10 | 16.53 | 17.80 |
Cash at End of Period | 43.82 | 43.37 | 53.55 | 42.10 | 16.53 |
Diluted Net EPS | -0.91 | -0.74 | -0.75 | -0.77 | -1.80 |
Fiscal Year End for CorMedix Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
9/30/2024 | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -28.62 | -14.47 | -46.34 | -31.59 | -21.84 |
Depreciation/Amortization & Depletion | 0.17 | 0.06 | 0.21 | 0.15 | 0.10 |
Net Change from Assets/Liabilities | -6.61 | -5.35 | 2.23 | -0.51 | -0.50 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 3.71 | 2.44 | 5.49 | 4.28 | 3.27 |
Net Cash From Operating Activities | -31.35 | -17.31 | -38.41 | -27.66 | -18.97 |
Property & Equipment | -0.10 | -0.06 | -0.33 | -0.03 | -0.02 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 15.31 | 9.01 | -16.73 | -17.63 | -17.05 |
Other Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | 15.21 | 8.94 | -17.06 | -17.66 | -17.07 |
Uses of Funds
9/30/2024 | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 1.20 | 0.00 | 56.12 | 55.65 | 12.75 |
Issuance (Repayment) of Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | -0.24 | -0.10 | -0.20 | -0.20 | -0.20 |
Net Cash from Financing Activities | 0.96 | -0.10 | 55.92 | 55.45 | 12.55 |
Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | -15.18 | -8.46 | 0.45 | 10.13 | -23.49 |
Cash at Beginning of Period | 43.82 | 43.82 | 43.37 | 43.37 | 43.37 |
Cash at End of Period | 28.65 | 35.36 | 43.82 | 53.50 | 19.89 |
Diluted Net EPS | -0.25 | -0.25 | -0.25 | -0.17 | -0.25 |